Related Experiment Video
Updated: Jun 25, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy
Kazuyuki Matsushita1, Takeshi Tomonaga, Toshiko Kajiwara
1Chiba University, Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670. kmatsu@faculty.chiba-u.jp
Abstract:
Based on the genetic background of cancer, we have been trying to develop novel diagnostic and therapeutic strategies against human cancers. c-myc gene activation has been detected in many human cancers, indicating a key role of c-myc in tumor development. Thus targeting c-myc gene suppression is a promising strategy for cancer treatment. Recently, an interaction between FIR (FUSE-Binding Protein-Interacting Repressor) and TFIIH/p89/XPB helicase was found to repress c-myc transcription and so might be important for suppressing tumor formation. Previously, we have shown that the expression of splicing variant of FIR is elevated in colorectal cancer tissues and promotes tumor development by disabling FIR-repression to sustain high levels of c-Myc, opposing apoptosis in cancer cells. In this study, FIR recombinant adenovirus vector induces tumor growth suppression against tumor xenografts in animal model experiment. Together, one clue to the development of cancer diagnosis and therapies directed against c-Myc may go through FIR and its splicing variant.
Insights
Targeting the FUSE-Binding Protein-Interacting Repressor (FIR) and its splicing variant shows promise for cancer therapy. FIR can suppress tumor growth, offering new diagnostic and therapeutic strategies against c-Myc-driven cancers.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- c-myc gene activation is implicated in numerous human cancers, highlighting its role in tumor development.
- Targeting c-myc gene suppression presents a viable strategy for cancer treatment.
- FUSE-Binding Protein-Interacting Repressor (FIR) interacts with TFIIH/p89/XPB helicase to repress c-myc transcription, suggesting a role in tumor suppression.
Purpose of the Study:
- To investigate the role of FIR and its splicing variant in colorectal cancer.
- To evaluate the therapeutic potential of FIR in suppressing tumor growth.
Main Methods:
- Analysis of FIR splicing variant expression in colorectal cancer tissues.
- Utilizing a FIR recombinant adenovirus vector in animal models with tumor xenografts.
Main Results:
- Elevated expression of the FIR splicing variant was observed in colorectal cancer tissues, correlating with tumor promotion.
- The FIR splicing variant disables FIR-mediated repression, leading to sustained high levels of c-Myc and inhibiting apoptosis.
- FIR recombinant adenovirus vector administration resulted in tumor growth suppression in an animal model.
Conclusions:
- FIR and its splicing variant are critical regulators of c-Myc expression and play a significant role in colorectal cancer development.
- Targeting FIR presents a potential therapeutic strategy for c-Myc-driven cancers.
- Further research into FIR and its variants could lead to novel cancer diagnostic and therapeutic approaches.
Related Concept Videos
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
Master Transcription Regulators
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
